Table 2. Costs associated with vaccination using multidose vials and prefilled syringes in 2009 in the USA. Resources for 1000 doses MDVs ...

A high-level overview of Provident Financial Services, Inc. (PFS) stock. View (PFS) real-time stock price, chart, news, analysis, analyst reviews and more.

All values USD Millions. 2024 2023 2022 2021 2020 5-year trend; Total Deposits: 18,666: 10,329: 10,599: 11,268: 9,872 ...

Cite this: Vaccine Presentation in the USA: Economics of Prefilled Syringes versus Multidose Vials for Influenza Vaccination - Medscape - Nov 01, 2010. Abstract and Introduction ...

Provident Financial Services Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View PFS financial statements in full.

The PFS and OS benefits with relacorilant were observed across all prespecified subgroups, except for PFS in patients with BRCA1/2-mutant disease (HR, 1.08; 95% CI, 0.49-2.37). The survival benefits ...

Among patients with PD-L1-positive disease, the median PFS was 28.1 months in the dostarlimab-niraparib arm and 24.3 months in the niraparib arm (HR, 0.84; 95% CI, 0.61-1.17). The 1-year PFS rates ...